S9 à partir du foie, regroupé, 20 mg/ mL base protéique, à partir de la souris (CD - 1 ), mâle, 20 mg / mL base protéique,Fiole de 1,0 mL

Code: s2192-1vl D2-231

Non disponible en dehors du Royaume-Uni et de l'Irlande

Biochem/physiol Actions

The hepatic S9 pools from a variety of biological sources represent the post-mitochondrial supernatant fraction from homogenized liver. Known to be a ...


en savoir plus

Votre prix
£101.00 EACH

Non disponible en dehors du Royaume-Uni et de l'Irlande

Biochem/physiol Actions

The hepatic S9 pools from a variety of biological sources represent the post-mitochondrial supernatant fraction from homogenized liver. Known to be a rich source of drug metabolizing enzymes including P-450, these pools are useful in the study of xenobiotic metabolism and drug interactions.

The hepatic S9 pools from a variety of biological sources represent the post-mitochondrial supernatant fraction from homogenized liver. They are known to be a rich source of drug metabolizing enzymes including P-450. S9 pools are useful in the study of xenobiotic metabolism and drug interactions. They are used in the Ames test, which is a method that uses bacteria to test if a given chemical causes mutations in the genetic material of a given test organism.

Physical form

Supplied as a solution in 150 mM KCl, 50 mM Tris buffer, pH 7.2 and 2 mM EDTA.

biological sourcemouse (CD-1)
concentration20 mg/mL protein
Gene Informationmouse ... Rps9(76846)
packagingvial of 1.0 mL
Quality Level200
shipped indry ice
storage temp.−70°C
UniProt accession no.Q6ZWN5
Ce produit répond aux critères suivants: